RxDoctor Payments DataLook up a doctor →

Eric Johnson, MD

Family Medicine · Lincoln, NENPI 1528089174

Payments from drug & device makers

$10,224in general payments, 2019–2025

Across 454 payments — averaging $22.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • AbbVie$1K
  • Aimmune Therapeutics, Inc.$525
  • Novo Nordisk$498
  • Pfizer$478
  • Lilly USA, LLC$475
  • plus $4K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis12$2,383
AbbVie(2 entities)98$1,441
Aimmune Therapeutics, Inc.5$525
Novo Nordisk29$498
Pfizer32$478
Lilly USA, LLC46$475
Amgen29$400
Supernus Pharmaceuticals, Inc.11$370
Astellas Pharma US Inc12$340
AstraZeneca16$306
Bayer9$217
Abbott9$190
Otsuka America Pharmaceutical, Inc.9$177
Takeda Pharmaceuticals U.S.A., Inc.11$149
Antares Pharma, Inc.8$149
Corcept Therapeutics3$134
Actelion Pharmaceuticals US, Inc.2$107
Upsher-smith Laboratories LLC5$103
Boehringer Ingelheim6$96
Azurity Pharmaceuticals, Inc.1$93
Johnson & Johnson5$91
Ironwood Pharmaceuticals, Inc6$84
Exact Sciences5$82
Sunovion Pharmaceuticals Inc.10$76
Merck4$70
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$68
Biohaven Pharmaceuticals, Inc.4$64
Axsome Therapeutics, Inc.4$61
Sanofi-aventis U.S. LLC4$57
Boston Scientific3$54
Jazz Pharmaceuticals Inc.3$51
Adlon Therapeutics L.p.3$48
Medicure Pharma Inc.2$48
Stryker1$42
Biohaven Pharmaceutical Holding Company Ltd.2$42
Alkermes, Inc.2$41
Genentech USA, Inc.3$39
Ascensia Diabetes Care US Inc.2$36
Organon2$34
Nestle Healthcare Nutrition Inc.2$32
Mylan Specialty L.p.2$32
Esperion Therapeutics, Inc.2$31
Impel Pharmaceuticals Inc.2$30
Kowa Pharmaceuticals America, Inc.2$30
Nalu Medical, Inc.1$27
Phathom Pharmaceuticals, Inc.3$26
Resmed Corp1$23
Radius Health, Inc.1$21
Lundbeck LLC1$20
Mayne Pharma Commercial LLC1$18
Bausch Health US, LLC1$18
Ultragenyx Pharmaceutical Inc.1$17
Sun Pharmaceutical Industries Inc.1$17
Inspire Medical Systems, Inc.1$16
Xeris Pharmaceuticals, Inc.1$15
GSK1$14
Shire North American Group Inc1$14
Dexcom, Inc.1$14
Teva Pharmaceuticals USA, Inc.1$14
Ardelyx, Inc.1$14

How this compares

$10,224 in reported general payments places this provider in the 95th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$112,975
Medicare patients
462
Services billed
4,252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →